As shown in Fig 5C and 5D, there was a significant increase of the phosphorylation of AKT in STZ-treated groups (P < 0.01), and a significant increase of PI3K in STZ-treated groups, which suggested that STZ-induced gestational diabetes promoted the expression of PI3K and its downstream activation of AKT. The gene discussed is AKT1; the disease is gestational diabetes.